Mayo Clinic Minute: Know The Warning Signs of Hypertrophic Cardiomyopathy

Translate to Spanish or other 102 languages!

It's often silent but can be a deadly killer. Hypertrophic cardiomyopathy is a genetic condition that occurs in 1 in 500 people. Image for illustration purposes
It’s often silent but can be a deadly killer. Hypertrophic cardiomyopathy is a genetic condition that occurs in 1 in 500 people. Image for illustration purposes
- Advertisement -

By Jason Howland / Mayo Clinic News Network

It’s often silent but can be a deadly killer. Hypertrophic cardiomyopathy is a genetic condition that occurs in 1 in 500 people.

Dr. Said Alsidawi, a Mayo Clinic cardiologist, says the problem is that many people don’t even know they have it because they have no symptoms. And in 20% of cases, the first presentation is sudden cardiac death. 

- Advertisement -

Watch: The Mayo Clinic Minute

Video courtesy of “Mayo Clinic News Network.” Read the script.

Hypertrophic cardiomyopathy is a genetic condition that causes the heart muscle to thicken, making it harder to pump blood and sometimes causing an irregular heart rhythm.

“So right now, what we think in the United States, we’ve only diagnosed 1/7 of the people who have hypertrophic cardiomyopathy. So we’re trying to increase the awareness in the community about this disease,” says Dr. Alsidawi.

He says patients are born with a genetic mutation. The disease can start at a young age or later in life — many times with no symptoms.  

- Advertisement -

“We know the patients that we lose to this condition, the majority of them are young, active and athletes. So high-level athletic exercise can put you at higher risk of sudden cardiac death,” says Dr. Alsidawi.

He says it’s important to seek medical attention if you have any symptoms, especially with exertion, “including shortness of breath, chest pain, lightheaded, dizzy or passing out.”

If diagnosed, the good news is hypertrophic cardiomyopathy can be treated with medications, surgery, implanting a defibrillator that monitors the heart or, in severe cases, heart transplantation.  

Additional resources:

Information Source: Mayo Clinic News Network

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves First Heart Valve Designed to Grow with Children

The U.S. Food and Drug Administration today approved the Autus Size-Adjustable Valve, a surgically implanted pulmonary heart valve for pediatric patients with congenital pulmonary valve disease.

DHR Health Offers Mammogram Screening Special During “Breast Cancer Awareness Month”

October is “Breast Cancer Awareness Month,” and DHR Health is encouraging women to prioritize their breast health by offering their annual mammogram screening special.

Healthy Lifestyle Changes to Effectively Manage AFib

As alarming as an AFib diagnosis can be, it can give a person a chance to take control of contributing factors they can change, said Dr. Lee L. Eckhardt, a professor of medicine at the University of Wisconsin-Madison. People who learn they have AFib can change their habits in ways that may lower their risks over time.

How Robotic Innovation is Transforming Breast Cancer Surgery

October is Breast Cancer Awareness Month. Reports show one in eight women in the United States will develop breast cancer, and some may have to undergo a mastectomy, which can now be performed robotically.
- Advertisement -